Novabay Pharmaceuticals Inc (AMEX:NBY)’s traded shares stood at 0.44 million during the latest session, with the company’s beta value hitting 2.02. At the last check today, the stock’s price was $0.08, to imply a decrease of -3.45% or $0.0 in intraday trading. The NBY share’s 52-week high remains $1.95, putting it -2337.5% down since that peak but still an impressive 12.5% since price per share fell to its 52-week low of $0.07. The company has a valuation of $2.92M, with an average of 3.49 million shares over the past 3 months.

Novabay Pharmaceuticals Inc (AMEX:NBY) trade information

After registering a -3.45% downside in the latest session, Novabay Pharmaceuticals Inc (NBY) has traded red over the past five days. The stock hit a weekly high of 0.1000, dropping -3.45% in its intraday price action. The 5-day price performance for the stock is -10.29%, and -42.07% over 30 days. With these gigs, the year-to-date price performance is -60.25%.

Novabay Pharmaceuticals Inc (NBY) estimates and forecasts

Looking at statistics comparing Novabay Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. Novabay Pharmaceuticals Inc (NBY) shares are -78.77% down over the last 6 months, with its year-to-date growth rate higher than industry average at 87.76% against 10.20%.

NBY Dividends

Novabay Pharmaceuticals Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Novabay Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.